Israeli researchers achieve new lymphoma treatment posting 100% survival rates
2 days ago
- #hematology
- #medical breakthrough
- #lymphoma
- Israeli study presents innovative lymphoma treatment with 100% survival rate at ASH conference.
- Treatment combines chemotherapy and biological therapy, achieving 95% complete response and 83% near-total disease disappearance after two cycles.
- Only 4% of patients required additional radiation, with manageable side effects and 100% one-year survival.
- Hodgkin lymphoma, accounting for 10% of lymphomas, is highly curable with rates exceeding 85%.
- New treatment protocol enables full disease control or cure in just nine weeks.
- Israeli study confirms German Lancet findings, showing high efficacy and better tolerability.
- Israel leads in hematology, being among the first to implement new research in treatment protocols.